Description
FLAMMA is a family owned & run, award winning, fully integrated CDMO with Headquarters located near Milan, Italy. FLAMMA specializes in the cGMP manufacturing of small molecule APIs, NCEs, RSMs & advanced intermediates. FLAMMA has significant expertise in high value chiral materials (specifically amino acid related materials used in peptide drugs). FLAMMA provides manufacturing options for the entire life cycle of a small molecule drug.
FLAMMA can provide assistance for early stage pre-clinical development (from g to kg using our facility located outside of Philadelphia in the USA) to large-scale commercial manufacturing (from 100’s of kg to MT) at one of our three facilities located in Italy. FLAMMA’s 100% owned and self-managed facility in Dalian, China allows one to leverage its offerings to provide a stable and secure supply chain. With over 850 employees and a total capacity of 1,100 m3 (900 m3 in Italy and 200 m3 in China), learn why FLAMMA is a preferred supplier to the pharmaceutical and biotech industry. Visit FlammaGroup.com for further information.
Type of Drugs Manufactured:
Small Molecule
CDMO Services offer:
Drug Substance Manufacturing (API)
No. of Manufacturing Facilities:
3-5
High Potent Products capabilities:
OEB 3;OEB 4-5
Facilities Locations:
Europe;North America;China
Current Capacity:
Manufacturing Information
Capabilities
- Analytical Services
 - APIs (Active Pharmaceutical Ingredients)
 - cGMP Synthesis
 - Chemistry (CMC)
 - Clinical Trials
 - Containment
 - Contract Development and Manufacturing (CDMO)
 - Contract Research (CRO)
 - Custom Synthesis
 - Cytotoxic & High Potency Compounds
 - Drug Development
 - Drug Substance Manufacturing (API)
 - Fine Chemicals
 - Generics
 - High Containment Operations
 - High Potency
 - ICH
 - Nutraceuticals
 - Oligonucleotides
 - Organic Synthesis
 - Peptides
 - Process Development
 - Process Validation Studies
 - Project Management
 - Quality QA/QC
 - Raw Materials
 - Regulatory Services
 - Research & Development
 - Scale-Up
 - Small Molecule
 - Stability Studies
 - Validation